Dupont Capital Management Corp lessened its stake in shares of AmerisourceBergen (NYSE:ABC) by 92.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,327 shares of the company’s stock after selling 16,975 shares during the quarter. Dupont Capital Management Corp’s holdings in AmerisourceBergen were worth $114,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Hikari Tsushin Inc. purchased a new stake in AmerisourceBergen during the 4th quarter worth about $106,000. Delpha Capital Management LLC purchased a new stake in AmerisourceBergen during the 4th quarter worth about $137,000. Vantage Investment Advisors LLC purchased a new stake in AmerisourceBergen during the 4th quarter worth about $156,000. TRUE Private Wealth Advisors purchased a new stake in AmerisourceBergen during the 4th quarter worth about $203,000. Finally, IBM Retirement Fund purchased a new stake in AmerisourceBergen during the 4th quarter worth about $216,000. Hedge funds and other institutional investors own 66.86% of the company’s stock.
Several analysts have commented on ABC shares. TheStreet upgraded AmerisourceBergen from a “c” rating to a “b” rating in a report on Tuesday, February 6th. Argus lifted their price target on AmerisourceBergen from $93.96 to $115.00 and gave the company a “buy” rating in a report on Monday, March 5th. Cowen restated a “buy” rating and issued a $108.00 price target on shares of AmerisourceBergen in a report on Tuesday, February 27th. Bank of America started coverage on AmerisourceBergen in a report on Tuesday, February 27th. They issued a “buy” rating and a $111.00 price target for the company. Finally, Zacks Investment Research upgraded AmerisourceBergen from a “hold” rating to a “buy” rating and set a $103.00 price target for the company in a report on Thursday, February 8th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the stock. AmerisourceBergen has an average rating of “Hold” and an average price target of $103.07.
AmerisourceBergen (NYSE:ABC) last released its quarterly earnings data on Wednesday, May 2nd. The company reported $1.96 earnings per share for the quarter, beating the consensus estimate of $1.83 by $0.13. The business had revenue of $41.03 billion for the quarter, compared to analyst estimates of $40.56 billion. AmerisourceBergen had a return on equity of 51.04% and a net margin of 0.57%. The company’s revenue was up 10.5% compared to the same quarter last year. During the same period in the previous year, the company posted $1.77 EPS. sell-side analysts expect that AmerisourceBergen will post 6.49 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 4th. Stockholders of record on Monday, May 21st will be paid a $0.38 dividend. This represents a $1.52 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Friday, May 18th. AmerisourceBergen’s dividend payout ratio is currently 25.85%.
In other news, insider Robert P. Mauch sold 1,000 shares of AmerisourceBergen stock in a transaction dated Wednesday, February 28th. The stock was sold at an average price of $97.94, for a total value of $97,940.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, insider Peyton R. Howell sold 3,000 shares of AmerisourceBergen stock in a transaction dated Wednesday, March 7th. The shares were sold at an average price of $93.78, for a total value of $281,340.00. Following the completion of the transaction, the insider now directly owns 49,189 shares in the company, valued at $4,612,944.42. The disclosure for this sale can be found here. Insiders sold a total of 114,092 shares of company stock worth $10,136,544 over the last ninety days. Corporate insiders own 27.30% of the company’s stock.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Want to see what other hedge funds are holding ABC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AmerisourceBergen (NYSE:ABC).
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.